TIRZEPATIDE, A DUAL GIP/GLP-1 RECEPTOR CO-AGONIST FOR THE TREATMENT OF TYPE 2 DIABETES WITH UNMATCHED EFFECTIVENESS REGRADING GLYCAEMIC CONTROL AND BODY WEIGHT REDUCTION

Descargar Publicación
Factors Showing the Growing Relation Between Vitamin D, Metabolic Syndrome, and Obesity in the Adult Population: A Systematic Review COVID-19 associated diabetes mellitus: A review